Standard pen test scoping frameworks weren't built for pharma. Learn how to scope an engagement that covers validated systems under 21 CFR Part 11 and protects high-value formulation and clinical data from targeted threats.

Semiconductor manufacturers face dual compliance obligations under CMMC 2.0 and the CHIPS Act and a standard pen test satisfies neither fully. Learn how to build a unified program that covers both frameworks.

Completing a pen test isn't enough for CMMC. Learn what C3PAO assessors actually look for in your evidence package and how to align your report, scope, POA&M, and remediation docs to specific practice statements.

Annual penetration testing produces documentation, not security. Learn how Penetration Testing as a Service fits manufacturing's high-change OT environments and closes the gap between discovery and fix.

Don't wait for an auditor to tell you what you missed. Learn how to build an OT attack surface map using passive discovery, zone mapping, and risk-based prioritization before your next security audit.